http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104211774-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-04 |
| filingDate | 2014-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104211774-B |
| titleOfInvention | Thymopeptide-5 special type superfine powder lyophilized formulations and preparation method thereof |
| abstract | The invention discloses a kind of thymopeptide-5 special type superfine powder lyophilized formulations and preparation method thereof; thymopeptide-5 special type superfine powder lyophilized formulations are with Wang resins as initiation material; amino acid with Fmoc protections is as monomer; first amino acid uses Fmoc Tyr (tBu) OH, with HBTU as condensing agent, amino acid is connected one by one; by cutting peptide; purification, air flow super is freezed and is obtained.Thymopeptide-5 special type superfine powder lyophilized formulations of the invention have the advantages that clarity is good, stability is high, purity is high, impurity is few, particle is small, specific surface area is big, dissolubility is good, toxic and side effect is small, be difficult allergy. |
| priorityDate | 2014-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 66.